Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism RORG inverse agonists(Nuclear receptor ROR-gamma inverse agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Preclinical | US | - | |
Psoriasis | Preclinical | US | - | |
Rheumatoid Arthritis | Preclinical | US | - | |
Systemic Lupus Erythematosus | Preclinical | US | - | |
Solid tumor | Discovery | US | - |